Literature DB >> 27051381

Managing diabetic ketoacidosis in pregnancy.

Gómez-Ríos Má1, Gómez-Ríos D1, Paech Mj2, Diéguez-Fernández M1.   

Abstract

Entities:  

Year:  2016        PMID: 27051381      PMCID: PMC4799622          DOI: 10.4103/1658-354X.168829

Source DB:  PubMed          Journal:  Saudi J Anaesth


× No keyword cloud information.
Sir, Diabetic ketoacidosis (DKA) is a potentially life-threatening condition in pregnancy,[1] affecting 0.5-3% of diabetic pregnancies.[2] We describe a woman who developed DKA due to insulin pump malfunction. A 35-year-old nulliparous diabetic, usually well-managed with a subcutaneous insulin pump, presented at 33 weeks gestation with malaise, vomiting, Kussmaul breathing and uterine contractions. Vital signs were, blood pressure 140/70 mmHg, heart rate 110 beats/min, respiratory rate 25 breaths/min and temperature 37°C. Laboratory tests were abnormal [Table 1]. The fetal heart trace showed poor variability, with late decelerations. In the intensive care unit, she received intravenous 0.9% normal saline (2 L over 3 h), then plasmalyte solution at 250 ml/h); insulin 10 u/h; and intravenous potassium. Her clinical and metabolic condition improved over 24 h [Table 1] and both contractions and late decelerations resolved. She was later discharged with a new subcutaneous insulin pump and was delivered uneventfully by elective cesarean section at 37 weeks.
Table 1

Sequential blood results for 24 h following admission

Sequential blood results for 24 h following admission Pregnancy constitutes a state of insulin resistance, accelerated starvation and respiratory alkalosis with compensatory renal bicarbonate excretion, predisposing to DKA.[2] Increased insulin resistance and/or inadequate insulin[3] may lead to hormonal-induced release of alternative energy substrates,[1] with uncontrolled hyperglycemia, dehydration, loss of electrolytes (osmotic diuresis), ketosis and metabolic acidosis.[2] The physiological response is a self-perpetuating chain of events, involving increased respiratory rate and depth (Kussmaul respiration) and compensatory low serum bicarbonate, producing an abnormal high anion gap[1] [Figures 1 and 2].
Figure 1

Pathophysiology of diabetic ketoacidosis during pregnancy. (DM: Diabetes mellitus; CH: Carbohydrates; Phos: Phosphates; aa: Amino acids)

Figure 2

Algorithm for diagnosis and treatment of diabetic ketoacidosis in pregnancy. (Tt: Treatment; Dx: Diagnosis; sc: Subcutaneous)

Pathophysiology of diabetic ketoacidosis during pregnancy. (DM: Diabetes mellitus; CH: Carbohydrates; Phos: Phosphates; aa: Amino acids) Algorithm for diagnosis and treatment of diabetic ketoacidosis in pregnancy. (Tt: Treatment; Dx: Diagnosis; sc: Subcutaneous) Fetal distress follows compromised uteroplacental perfusion (maternal volume depletion, acidemia and increased catecholamines),[3] and hypoxemia (decreased 2,3-diphosphoglycerate secondary to maternal hypophosphatemia).[4] Fetal hyperglycemia depletes the intravascular volume and hyperinsulinemia increases oxygen demand, depresses myocardial contractility, and combined with hypokalemia, contributes to fatal arrhythmias.[1] These changes are reversible if maternal metabolic stability is achieved.[124] Maternal treatment must be aggressive, with reassessment of biochemical parameters 1-2 hours [Figure 2]. Intravascular volume restoration and intravenous insulin are of the highest priority to improve systemic perfusion and peripheral insulin release. Isotonic saline is mandated initially because hypotonic solutions decrease plasma osmolality (risking brain edema),[2] whereas subsequently balanced crystalloid solutions prevent iatrogenic hyperchloremic metabolic acidosis and hypernatremia.[1] Insulin corrects hyperglycemia, inhibits lipolysis and ketogenesis, suppresses hepatic glucose production and contributes to ketone body degradation.[1] Correction should be gradual, at ≤60-75 mg/dl/h, as rapidly changing serum osmolality can precipitate cerebral edema or central pontine myelinolysis.[4] Paradoxical worsening of ketoacidemia is explained by the preferential reduction of β-hydroxybutyric acid (ideally measured directly) compared with acetoacetate, which is converted to acetone, thus increasing ketone levels.[5] Initially reduced the cellular uptake of potassium, compounded by protein degradation, predisposes to elevated serum levels, despite low total body content. Once intravenous fluid and insulin therapy are established, serum potassium may fall markedly, intravenous replacement being recommended once the concentration is below 5 mEq/L.[4] Sodium bicarbonate does not improve outcomes and may cause harm from hypokalemia, hypernatremia, metabolic alkalosis, decreasing cerebrospinal fluid pH and compromised fetal oxygenation by left-shift of the oxygen-hemoglobin dissociation curve.[4] Diabetic ketoacidosis in pregnancy is a medical and obstetrical emergency requiring coordinated, early aggressive treatment on a specialized unit.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

Review 1.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes.

Authors:  L Laffel
Journal:  Diabetes Metab Res Rev       Date:  1999 Nov-Dec       Impact factor: 4.876

Review 2.  Diabetic ketoacidosis in pregnancy.

Authors:  Mary Anne Carroll; Edward R Yeomans
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

Review 3.  Diabetic ketoacidosis in pregnancy.

Authors:  Baha M Sibai; Oscar A Viteri
Journal:  Obstet Gynecol       Date:  2014-01       Impact factor: 7.661

Review 4.  Diabetic ketoacidosis in pregnancy.

Authors:  Jason A Parker; Deborah L Conway
Journal:  Obstet Gynecol Clin North Am       Date:  2007-09       Impact factor: 2.844

Review 5.  Diabetes ketoacidosis in pregnancy.

Authors:  Margarita de Veciana
Journal:  Semin Perinatol       Date:  2013-08       Impact factor: 3.300

  5 in total
  2 in total

1.  Resolution of severe fetal distress following treatment of maternal diabetic ketoacidosis.

Authors:  Yang Huang Grace Ng; Tat Xin Ee; Devendra Kanagalingam; Hak Koon Tan
Journal:  BMJ Case Rep       Date:  2018-03-09

2.  Effect of Continuous Subcutaneous Injection of Insulin Analogues in Pregnant Women with Diabetes Mellitus Complicated with Ketoacidosis.

Authors:  Yunfei Pan; Qi Wang; Feimin Zhao; Jiaying Shen; Xiaojing Zhong
Journal:  J Healthc Eng       Date:  2021-12-15       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.